1.96
price up icon5.38%   0.10
after-market Handel nachbörslich: 1.95 -0.01 -0.51%
loading

Finanzdaten der Immuneering Corp-Aktie (IMRX)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
5.99%
15.33
16.30 13.93 13.50 14.68
Operating Income/Loss
5.99%
-15.33
-16.30 -13.93 -13.50 -14.68
Income/Loss From Continuing Operations Before Tax
5.14%
-14.31
-15.08 -12.60 -12.19 -13.60
Income/Loss From Continuing Operations After Tax
5.14%
-14.31
-15.08 -12.60 -12.19 -13.60
Net Income/Loss
5.14%
-14.31
-15.08 -12.60 -12.19 -13.60
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
10,114%
29.37
0.2876 29.27 28.65 26.44
Diluted Average Shares
10,114%
29.37
0.2876 29.27 28.65 26.44
Basic Earnings Per Share
5.77%
-0.49
-0.52 -0.43 -0.43 -0.51
Diluted Earnings Per Share
5.77%
-0.49
-0.52 -0.43 -0.43 -0.51
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
Kapitalisierung:     |  Volumen (24h):